Potential repurposed SARS-CoV-2 (COVID-19) infection drugs-Reference-Cited by-同舟云学术

Potential repurposed SARS-CoV-2 (COVID-19) infection drugs

Published:2020 Issue:45 Volume:10 Page:26895-26916
ISSN:2046-2069
Container-title:RSC Advances
language:en
Short-container-title:RSC Adv.

Author:

Abuo-Rahma Gamal El-Din A.¹²³⁴⁵^ORCID,Mohamed Mamdouh F. A.⁶²⁷⁸⁵^ORCID,Ibrahim Tarek S.⁶²⁹¹⁰¹¹,Shoman Mai E.¹²³⁴⁵,Samir Ebtihal¹²²¹³¹⁴⁵,Abd El-Baky Rehab M.¹⁵²³⁴⁵

Affiliation:

1. Department of Medicinal Chemistry

2. Faculty of Pharmacy

3. Minia University

4. 61519 Minia

5. Egypt

6. Department of Pharmaceutical Chemistry

7. Sohag University

8. 82524 Sohag

9. King Abdulaziz University

10. Jeddah

11. Saudi Arabia

12. Physical Chemistry, Department of Analytical Chemistry

13. Deraya University

14. Minia 11566

15. Department of Microbiology and Immunology

Abstract

The global outbreak of COVID-19 viral infection is associated with the absence of specific drug(s) for fighting this viral infection.

Publisher

Royal Society of Chemistry (RSC)

Subject

General Chemical Engineering,General Chemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2020/RA/D0RA05821A

Reference203 articles.

1. C. C.-U. F. R. E. U. A. f. C. H. and U. S. F. D. A. , https://www.fda.gov/news-events/pressannouncements/coronavirus-covid-19-update-fda-revokes-emergency-useauthorization-chloroquine-and. , published 2020, accessed June 15, 2020, 2020

2. Emerging and Neglected Infectious Diseases: Insights, Advances, and Challenges

3. Disease Manifestations and Pathogenic Mechanisms of Group A Streptococcus

4. Emerging infectious diseases

5. After 2015: infectious diseases in a new era of health and development

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Computational insight of repurpose drug for treatment of COVID-19: a CDFT approach;Theoretical Chemistry Accounts;2023-12-27

2. Can Nitazoxanide and/or other anti‐viral medications be a solution to long COVID? Case report with a brief literature review;Clinical Case Reports;2023-11

3. Characterization of SARS-COV-2 main protease inhibitory peptides from Ulva prolifera proteins;Journal of Oceanology and Limnology;2023-07-05

4. Structure-Based Drug Design of RdRp Inhibitors against SARS-CoV-2;Topics in Current Chemistry;2023-06-15

5. In silico screening, ADMET analysis and MD simulations of phytochemicals of Onosma bracteata Wall. as SARS CoV-2 inhibitors;3 Biotech;2023-05-31